
Acquired by Bayer's Medrad unit
|
Medical devices for the treatment of peripheral arterial disease. |
![]() |
|
Bayer's Medrad unit acquired Pathway for $125 million in 2011 |
FoundersThomas J. Clement, David C. Auth |
|
Fields of invesment: |
Contact info: |